Our former postdoc, Miffy, led work on developing a theranostic nanoparticle for PSMA-targeted SPECT imaging and photodynamic therapy. Her recent paper was selected for a supplementary cover 🙌🎉🙌 @ACSBioMed @ACS4Authors. Read her paper here: https://t.co/xIXYPNVoY7 #MyACSCover https://t.co/Zbai2yIRMg

Read some of our more recent publications!
- Targeted Theranostic 111In/Lu-Nanotexaphyrin for SPECT Imaging and Photodynamic Therapy
- Synthesis and Characterization of Multi-Modal Phase-Change Porphyrin Droplets
- Repeated porphyrin lipoprotein-based photodynamic therapy controls distant disease in mouse mesothelioma via the abscopal effect
- Porphyrin-lipid nanovesicles (Porphysomes) are effective photosensitizers for photodynamic therapy
- Porphyrin-lipid stabilized paclitaxel nanoemulsion for combined photodynamic therapy and chemotherapy